GSM256361[Accession] - GEO DataSets

Select item 2000201401.

Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma

(Submitter supplied) Background: Hepatocellular carcinoma (HCC) is among the top-five cancer killers worldwide. Here, we describe our analysis of 20 gene signatures with reported prognostic value in a cohort of patients with early stage HCC treated with surgical resection. Methods: We performed gene-expression profiling of 164 formalin-fixed, paraffin-embedded HCC from three hepatology centers participating the HCC Genomic Consortium. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platforms:: GPL18461 GPL5474 GPL8432
620 Samples

Download data: TXT

Series

Accession:: GSE20140

ID:: 200020140

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 2000101432.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL5474
387 Samples

Download data: TXT

Series

Accession:: GSE10143

ID:: 200010143

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 2000101403.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, Liver)

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...